Seeing Is Believing
Currently out of the existing stock ratings of Dewey Steadman, 40 are a BUY (68.97%), 18 are a HOLD (31.03%).
Analyst Dewey Steadman, carries an average stock price target met ratio of 48.73% that have a potential upside of 19.68% achieved within 224 days. Previously, Dewey Steadman worked at CANACCORD.
Dewey Steadman’s has documented 113 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AERI, Aerie Pharmaceuticals at 10-Jun-2019.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 1/2/2019. The price target of $20 was fulfilled within 5 days with a profit of $6.03 (43.16%) receiving and performance score of 86.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$13
3 years 1 months 11 days ago
(28-Aug-2022)
1/5 (20%)
$4.7 (56.63%)
176
Hold
3 years 1 months 16 days ago
(23-Aug-2022)
0/1 (0%)
$6.53 (25.64%)
Hold
$20
3 years 1 months 16 days ago
(23-Aug-2022)
0/4 (0%)
$14.21 (245.42%)
Buy
$15.25
$27
3 years 1 months 17 days ago
(22-Aug-2022)
7/11 (63.64%)
$0.09 (0.59%)
149
Hold
$14
3 years 1 months 17 days ago
(22-Aug-2022)
6/14 (42.86%)
$6.36 (83.25%)
228
What Year was the first public recommendation made by Dewey Steadman?